Ebit 変化する 日付
AbbVie USD 6.88B 156M 2026-09
Alaunos Therapeutics USD -952K 60K 2026-06
Amgen USD 4.68B 65M 2026-09
Ardelyx USD -10.39M 20.29M 2026-06
Arrowhead Research USD -154.34M 13.08M 2026-06
Bayer EUR 129M 626M 2026-09
Biogen USD 419.5M 663.3M 2026-09
Corcept Therapeutics USD 114.72M 73.42M 2026-09
Curis USD -11.52M 3.64M 2026-03
Gilead Sciences USD 3.85B 1.17B 2026-06
J&J USD 6.47B 1B 2026-09
Karyopharm Therapeutics USD -26.76M 8.92M 2026-03
Novartis USD 5.14B 411M 2026-09
Novavax USD 20.94M 100.32M 2025-12
PTC Therapeutics USD 146.03M 100.14M 2026-06
Puma Biotechnology USD -2.2M 11.41M 2024-06
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
TG Therapeutics USD 85.9M 64.22M 2026-09
Verastem USD -44.9M 3.42M 2026-03
Vertex Pharmaceuticals USD 1.26B 11.3M 2026-09